SC

Suguna Charantu

Active Director Designated Partner DIN 08213056
DIN 08213056 First appointment Sep 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Suguna Charantu

Data last updated:

Suguna Charantu is a Designated Partner at Lps Life Sciences Llp (since 2018). The company operates in Business Services.

DIN 08213056
Primary Designation Designated Partner
Industry Business Services
First Appointment 25 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Sep 20182018Active

Board colleagues of Suguna Charantu

NameDINCompanyDesignation
Jagan Mohan Reddy Veluri08178772Lps Life Sciences LlpDesignated Partner
Venkata Lakshmi Konda07497128Lps Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Lps Life Sciences Llp
Premium access

Shareholding and investment profile for Suguna Charantu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suguna Charantu

Suguna Charantu currently holds 1 directorship: Lps Life Sciences Llp (Designated Partner, since 25 Sep 2018).

Suguna Charantu was first appointed on 25 Sep 2018 as Designated Partner at Lps Life Sciences Llp.

The current boards of Suguna Charantu's companies include Jagan Mohan Reddy Veluri (Lps Life Sciences Llp), Venkata Lakshmi Konda (Lps Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available